Anonymous ID: ffefad June 5, 2020, 8:28 a.m. No.9485718   ๐Ÿ—„๏ธ.is ๐Ÿ”—kun

>>9485680

The original PPP only allowed for small business to spend the money they borrowed during the 8 week period nearly everything was shutdown. That usage period has been extended to help fund restarting the small businesses.

Anonymous ID: ffefad June 5, 2020, 8:40 a.m. No.9485883   ๐Ÿ—„๏ธ.is ๐Ÿ”—kun   >>5902

SpouseAnon just got told by ExpressScripts no anti-depressant refill due to nationwide drug shortages.

 

Holy Shit. The current list of shortfalls is long. At least 200 drugs, including Hydroxycholoroquine, Chloroquin, blood thinners, antibiotics, steroidals, and much more.

 

Big Pharma still trying to kill us.

 

https://www.drugs.com/drug-shortages/

 

In 2018, the FDA developed a new Drug Shortages Task Force to explore the reasons and determine the root causes of why drug shortages remain an ongoing problem. The FDA worked with scientists and economists to review recent drug shortages. They interacted with the public, gathered comments, and worked with stakeholders such as patients, healthcare providers and pharmaceutical industry to better understand the causes of drug shortages and determine a solution.

 

 

Reference Current Drug Shortages

U.S. Drug Shortages: Root Causes and Recent Statistics

 

Print Share

U.S. Drug Shortages: Root Causes and Recent Statistics

 

Medically reviewed by Leigh Ann Anderson, PharmD Last updated on Dec 6, 2019.

Introduction

 

The highest standard of patient care is a top goal for every healthcare provider and institution in the United States. However, drug shortages can compromise a patientโ€™s medical care plan and result in dangerous outcomes. A patient's ability to have access to safe and lifesaving medications is a priority for the U.S. Food and Drug Administration (FDA). What is the FDA doing to address drug shortages?

 

In 2018, the FDA developed a new Drug Shortages Task Force to explore the reasons and determine the root causes of why drug shortages remain an ongoing problem. The FDA worked with scientists and economists to review recent drug shortages. They interacted with the public, gathered comments, and worked with stakeholders such as patients, healthcare providers and pharmaceutical industry to better understand the causes of drug shortages and determine a solution.

Which drugs are involved in U.S. drug shortages?

 

The FDA Task Force has worked to understand the drugs most commonly involved in drug shortages, as well as gain insight from patients, the public, industry, and the health care community. Based on this information, the FDA issued a report in October 2019 entitled "Drug Shortages: Root Causes and Potential Solutions" that attempts to identify the causes and offers recommendations for government and industry.

 

Drugs.com: Status of All Current U.S. Drug Shortages

 

The Task Force analyzed 163 drugs that went into a shortage between 2013 to 2017 and compared these products to similar drugs without shortages. Results revealed:

 

Low price and financially unattractive to industry; many shortages began due to discontinuation of products for commercial reasons.

More likely to be sterile injectables

Drug prices for the product rarely rose after the shortage began

During the shortage, production of the medication did not increase enough to reach pre-shortage levels.

 

https://www.drugs.com/drug-shortages/stats